Important Information


21st Century CURES Act

May 5, 2021

Get more information on the CURES Act


Johnson & Johnson (Janssen) COVID-19 vaccine information update

April 28, 2021

Get more information on the Janssen vaccine


COVID-19 phased reopening

March 12, 2021

As vaccination rates increase and hospitalizations decrease, we have carefully considered a phased operational strategy to ease some of the measures in place.

Read the full memo


Monoclonal antibody therapy

Medical City Healthcare now offers Bamlanivimab monoclonal antibody infusions, on a very limited basis, to patients who have tested positive for COVID-19 and have other high-risk factors. The FDA has authorized the emergency use of Bamlanivimab/Etesevimab for the treatment of COVID-19 under an Emergency Use Authorization (EUA). Medication supply is administered based upon availability. Patients must be referred by a Medical City Healthcare physician.

Learn more about this treatment